SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances higher full-year revenue outlook, reflecting stronger demand for Amtagvi and Proleukin, is driving attention and a sharp bullish reaction around the companys commercial growth. Traders are also watching for lung-cancer data, while short-squeeze and takeover talk remains speculative and some warn of profit-taking after the rally.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnivals quarterly results are drawing attention after a reported earnings and revenue beat, while its forward outlook is prompting debate. Bulls are celebrating the results and a possible short squeeze; skeptics point to softer near-term earnings guidance and elevated fuel costs.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobiles change-of-control severance policy has fueled speculation about a potential buyout or strategic deal, though traders also emphasize that the policy is not evidence an acquisition is underway. The discussion is divided between buyout hopes and skepticism, with delayed updates on BlueBirds 1416 shipments and launches a recurring concern.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for the U.S. Armys ALATTIS program to develop next-generation 10 kV silicon-carbide technology is driving attention, with traders viewing it as validation of the companys technology. The reaction is divided: bulls see longer-term potential, while skeptics note it is a prototype award with no disclosed value and question its near-term revenue impact as the initial pop fades.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas strategic investment in Summit and clinical collaboration around ivonescimab are driving attention, with traders welcoming the funding and big-pharma validation. The community is also emphasizing that the deal is not a buyout and does not settle the separate FDA approval question, while debating whether the share move will hold or fade.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

The FHFAs move to let Fannie Mae and Freddie Mac use VantageScore alongside FICO in mortgage pricing has raised concerns that FICOs long-standing advantage in mortgage credit scoring could weaken, driving a sharp selloff. Traders disagree on the impact: bears see a threat to its pricing power and moat, while bulls argue the market is overreacting and FICO remains an entrenched business.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

New four-year AMT-130 data for Huntingtons disease is driving attention: disease-progression slowing on the cUHDRS measure fell to 44% from 80% at three years and was no longer statistically significant, weighing on shares. Traders are divided, with skeptics questioning the treatments durability while bulls argue the FDA review is based on the previously submitted three-year data and cite patient dropouts in the external comparison group.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Elevated oil prices tied to the Iran conflict and reported disruption to Saudi oil infrastructure are weighing on cruise stocks, with traders concerned about fuel costs; some also point to NCLHs weaker yield outlook. Bulls call the shares oversold and cite high short interest as potential fuel for a rebound, while bears see further pressure if oil stays high or bookings soften.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

ZBCNs sharp move is prompting breakout and momentum chatter, with traders also speculating about Robinhood-related links and a possible BlackRock connection; the broader BlackRock tie-up remains unconfirmed. Some holders point to Zebecs payroll and card integrations as longer-term support, while skeptics question whether adoption is translating into sustained token demand.

Uranium Energy Corp. engages in the provision of uranium and titanium mining and related activities, including exploration, pre-extraction, extraction, and processing of uranium concentrates, and titanium minerals. It operates through the following geographical segments: Wyoming, Texas, Saskatchewan, and Others. The company was founded by Alan P. Lindsay and Amir Adnani on May 16, 2003 and is headquartered in Corpus Christi, TX.

Uranium Energy Corp

Uranium Energys fiscal 2026 results and operating update are drawing attention, with traders highlighting higher production, mine ramp-up progress and a debt-free balance sheet. The reaction is broadly positive on execution and domestic uranium-supply growth, though some remain cautious about ongoing losses and operational risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PLTR Palantir Technologies (NASDAQ:PLTR) is in many ways a study of contrasts.

There’s no doubt that the company’s fortunes have been rising over the past few years, and its revenues and profits have been ballooning. And yet, its strong growth runs into high valuations, making some investors wonder if they’re paying too much for the AI company.

The bearish viewpoint seemed to be winning out during the first half of 2026, with Palantir’s share price falling through the winter and spring months. The tide has been turning, however, over the past few months, and PLTR has been picking up steam.

Indeed, the company’s share price has surged by more than 60% during the last three months, and its strong U.S. commercial growth last quarter is providing plenty of confidence that things are on the up and up.

One top investor known by the pseudonym Oakoff Investments thinks that things are going to continue clickity clacking.

“Expect another leg up&quot;

Ashley Wolter

$PLTR replaced $MSFT at $DELL !!!$SPY replaced MSFT at $WMT of   Australia 🇦🇺!!! 
 
Story below.., 
https://m.youtube.com/watch?v=AcWsLQKIFW4&amp;pp=ygULQnAgcGFsYW50aXI%3D

StockTwits Web

StockTwits For Android 

Palantir Technologies Inc

 Palantir Technologies (NASDAQ:PLTR) is in many ways a study of contrasts.

There’s no doubt that the company’s fortunes have been rising over the past few years, and its revenues and profits have been ballooning. And yet, its strong growth runs into high valuations, making some investors wonder if they’re paying too much for the AI company.

The bearish viewpoint seemed to be winning out during the first half of 2026, with Palantir’s share price falling through the winter and spring months. The tide has been turning, however, over the past few months, and PLTR has been picking up steam.

Indeed, the company’s share price has surged by more than 60% during the last three months, and its strong U.S. commercial growth last quarter is providing plenty of confidence that things are on the up and up.

One top investor known by the pseudonym Oakoff Investments thinks that things are going to continue clickity clacking.

“Expect another leg up"